<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32024766</article-id>
<article-id pub-id-type="pmc">7002154</article-id>
<article-id pub-id-type="publisher-id">0518-19</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0518-19.2019</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Dual Perspectives</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-6585-8513</contrib-id>
<name>
<surname>Rehbach</surname>
<given-names>Kristina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernando</surname>
<given-names>Michael B.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-0993-5956</contrib-id>
<name>
<surname>Brennand</surname>
<given-names>Kristen J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Genetics and Genomics, </aff>
<aff id="aff2"><sup>2</sup>Friedman Brain Institute, </aff>
<aff id="aff3"><sup>3</sup>Graduate School of Biomedical Science, </aff>
<aff id="aff4"><sup>4</sup>Nash Family Department of Neuroscience, </aff>
<aff id="aff5"><sup>5</sup>Icahn Institute of Genomics and Multiscale Biology, and </aff>
<aff id="aff6"><sup>6</sup>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York 10029</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Kristen J. Brennand at <email>kristen.brennand@mssm.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>5</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>8</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>40</volume>
<issue>6</issue>
<fpage>1176</fpage>
<lpage>1185</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2020 the authors</copyright-statement>
<copyright-year>2020</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns00620001176.pdf"></self-uri>
<abstract abstract-type="precis">
<p>Human induced pluripotent stem cells (hiPSCs) have revolutionized research on human diseases, particularly neurodegenerative and psychiatric disorders, making it possible to study mechanisms of disease risk and initiation in otherwise inaccessible patient-specific cells. Today, the integration of CRISPR engineering approaches with hiPSC-based models permits precise isogenic comparisons of human neurons and glia.</p>
</abstract>
<abstract>
<p>Human induced pluripotent stem cells (hiPSCs) have revolutionized research on human diseases, particularly neurodegenerative and psychiatric disorders, making it possible to study mechanisms of disease risk and initiation in otherwise inaccessible patient-specific cells. Today, the integration of CRISPR engineering approaches with hiPSC-based models permits precise isogenic comparisons of human neurons and glia. This review is intended as a guideline for neuroscientists and clinicians interested in translating their research to hiPSC-based studies. It offers state-of-the-art approaches to tackling the challenges that are unique to human <italic>in vitro</italic> disease models, particularly interdonor and intradonor variability, and limitations in neuronal maturity and circuit complexity. Finally, we provide a detailed overview of the immense possibilities the field has to offer, highlighting efficient neural differentiation and induction strategies for the major brain cell types and providing perspective into integrating CRISPR-based methods into study design. The combination of hiPSC-based disease modeling, CRISPR technology, and high-throughput approaches promises to advance our scientific knowledge and accelerate progress in drug discovery.</p>
<p><bold>Dual Perspectives Companion Paper:</bold>
<related-article ext-link-type="doi" id="d35e174" related-article-type="companion" vol="40" xlink:href="10.1523/JNEUROSCI.0519-19.2019"><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1523/JNEUROSCI.0519-19.2019">Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids, by Ai Tian, Julien Muffat, and Yun Li</ext-link></related-article></p>
</abstract>
<kwd-group>
<kwd>Human induced pluripotent stem cells</kwd>
<kwd>CRISPR</kwd>
<kwd>psychiatric genetics</kwd>
<kwd>differentiation</kwd>
<kwd>induction</kwd>
<kwd>disease modeling</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>